Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma-Reference-Cited by-同舟云学术

Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma

Published:2015-04 Issue:4 Volume:26 Page:812-817
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bellmunt J.,Mullane S.A.,Werner L.,Fay A.P.,Callea M.,Leow J.J.,Taplin M.E.,Choueiri T.K.,Hodi F.S.,Freeman G.J.,Signoretti S.

Funder

Retired Professional Fire Fighters Cancer Fund and a private donation of the Whole Foods Market Charity Golf Classic for Bladder Cancer Research in memory of Chris Snell

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/4/812/16699455/mdv009.pdf

Reference29 articles.

1. Bladder cancer;Kaufman;Lancet,2009

2. Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens;Bellmunt;J Clin Oncol,2010

3. Comprehensive molecular characterization of urothelial bladder carcinoma;Cancer Genome Atlas Research N;Nature,2014

4. An antigen recognized by autologous CTLs on a human bladder carcinoma;Gueguen;J Immunol,1998

5. Immune mechanisms in bacillus Calmette–Guerin immunotherapy for superficial bladder cancer;Bohle;J Urol,2003

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition;Cancer Research Communications;2024-08-01

2. PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer;Scientific Reports;2024-07-20

3. Efficacy and safety of tislelizumab plus bacillus-calmette guérin with or without chemotherapy as a bladder-sparing treatment for high-risk non-muscle-invasive bladder urothelial cancer: a real-world study;Discover Oncology;2024-07-08

4. Evaluation of the Expression of Programmed Death-Ligand 1 and Its Role in Differentiating Low-Grade and High-Grade Urothelial Carcinoma;Cureus;2024-06-17

5. PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors;BMC Urology;2024-04-24